Intellect Neurosciences (ILNS.OB) Completes Financial Restructuring, Highlights Expectations for Alzheimer’s Drug
Intellect Neurosciences Inc. engages in the discovery and development of disease-modifying therapeutic agents for Alzheimer’s disease (AD). The company recently…